Critics claim Rule 11 concerning software classification in the scope of the EU Medical Device Regulation (MDR) is difficult to interpret and apply.
Such criticism has been leveled by many companies already familiar with the MDR, but interpreting Rule 11 has been particularly challenging for those who may be new to